Literature DB >> 6113262

Acyl-CoA:cholesterol acyltransferase in human small intestine: its activity and some properties of the enzymic reaction.

P Helgerud, K Saarem, K R Norum.   

Abstract

Esterification of endogenous cholesterol in human small intestinal mucosa by acyl-CoA:cholesterol acyltransferase (ACAT, EC 2.3.1.26) was studied using [1-14C]oleoyl-CoA as substrate. The reaction was linear for 2 min only. The esterification of cholesterol was stimulated by albumin, but this effect was dependent on the oleoyl-CoA concentration. When the albumin concentration was 5 g/liter, maximal esterification was obtained with 35 microM oleoyl-CoA. The pH optimum was 7.2-7.8. The ACAT specific activity was highest in microsomal preparations from jejunum (0.21 +/- 0.19 (n = 18) nmol cholesteryl oleate . mg microsomal protein-1 . min-1), and lower in proximal duodenum and distal ileum. Whole homogenates of biopsies had about 1/4 of the activity of the corresponding microsomal preparation. Microsomal preparations from jejunum contained acyl-CoA hydrolase (EC 3.1.2.2) which under the prevailing conditions had a maximal activity of 4.4 nmol oleate formed . microsomal protein-1 . min-1. The high activity of intestinal ACAT in man renders it possible that this enzyme plays a role in cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113262

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity.

Authors:  Ying Sun; Jiande Chen
Journal:  Obes Res       Date:  2004-08

Review 2.  Inhibition of acyl coenzyme A-cholesterol acyltransferase: a possible treatment of atherosclerosis?

Authors:  Therese M Heinonen
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

3.  Retinol esterification by microsomes from the mucosa of human small intestine. Evidence for acyl-Coenzyme A retinol acyltransferase activity.

Authors:  P Helgerud; L B Petersen; K R Norum
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.